Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 7, 2009; 15(25): 3086-3098
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3086
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3086
Animal model | Species | Advantages/disadvantages |
Surgical | ||
Total/partial hepatectomy | Pig, dog, rabbit, rat, mouse | Hepatic encephalopathy; reproducible/no reversibility; no long-term survival |
Total/partial devascularization | Pig, dog, rabbit, rat | Hepatic encephalopathy; reproducible/no reversibility; no long-term survival |
Chemical | ||
Acetaminophen | Pig, dog, rabbit, rat, mouse | Hepatic encephalopathy; no hazard/non-reproducible; variable interval between damage and death; species and age variability |
Amanitin | Pig | Hepatic encephalopathy; specific toxic effects; large animal |
Azoxymethane | Mouse | Hepatic encephalopathy; reproducible/small size; hazard |
Carbon tetrachloride | Pig, rabbit, rat, mouse | Hepatic encephalopathy/non reproducible; extrahepatic toxicity; small time window before death |
Concanavalin A | Rat, mouse | Hepatic encephalopathy/small size |
Galactosamine | Pig, dog, rabbit, rat, mouse | Hepatic encephalopathy; biochemical markers/non-reproducible; hazard; variable interval between damage and death; species differences |
Lipopolysaccharide | Rat, mouse | Hepatic encephalopathy/non-reproducible; small size; hazard; small time window before death |
Thioacetamide | Rabbit, rat, mouse | Hepatic encephalopathy; reproducible; large time window before death/hazard |
Viral | ||
Rabbit hemorrhagic disease | Rabbit | Hepatic encephalopathy; reproducible; no hazard |
Reversibility | Suitable treatment may reverse and improve survival |
Reproducibility | Reproducible end-points are required to standardize the model |
Death from liver failure | Should reflect biochemical, histological and clinical changes including death from AHF |
Therapeutic window | Time for treatment should be available between insult and death |
Adequate animal size | Size large enough to allow blood and tissue analysis to take place serially |
Minimal hazard to personnel | Minimum risk for operators and associated staff |
- Citation: Tuñón MJ, Alvarez M, Culebras JM, González-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 2009; 15(25): 3086-3098
- URL: https://www.wjgnet.com/1007-9327/full/v15/i25/3086.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3086